The Morning Bull - UK Market Morning Update Monday, 2 Nov 2026
UK equities are set for a slightly firmer open, with FTSE 100 futures edging up despite a weaker global equity tone. The single driver today is the Bank of England meeting on Thursday and what it signals on interest rates.
Markets are working off expectations that the BoE lifts Bank Rate from 3.75% to 4% on 5 November, while possibly pushing back on the idea of a long series of hikes. Oil prices remain elevated as geopolitics support an energy risk premium, keeping the inflation question live.
Higher energy costs tend to feed through into headline inflation and inflation expectations, which matters directly for BoE thinking on how restrictive rates need to be. That in turn influences borrowing costs for UK households and companies, shaping the earnings outlook for more debt dependent sectors.
The unresolved issue is how hard the BoE leans against future hikes if inflation is still driven by supply side energy shocks. Thursday's Monetary Policy Report and vote split will test whether current market pricing for UK rates is too aggressive or too cautious.
Stocks to Watch Before the Opening Bell
AstraZeneca (AZN)
Regulators in Europe and Japan have accepted filings for AstraZeneca's lung cancer treatment TAGRISSO, used with HUTCHMED's ORPATHYS, for MET driven, EGFR mutated non small cell lung cancer after progression on EGFR TKI therapy. The submissions rest on Phase III SAFFRON trial data, so attention now turns to review timelines and any regulatory feedback.
Anglo American (AAL)
A broad report on global resource supply points to tight markets for energy, metals and agricultural products, with Chilean copper output under strain and strong central bank demand for gold. Comments from former Anglo American chief Mark Cutifani highlight risks if large miners underinvest in new technology. Readers should watch how Anglo American frames capital spending and project lead times.
Ninety One Group (N91)
Ninety One Group has published a report describing a shift in commodities from a China led super cycle to a market shaped by constrained supply and geopolitical fragmentation. The research flags rising electricity needs from AI and data centres as a key driver for energy and metals. Fund flows into Ninety One products geared to these themes will be a focal point.
Top Movers
-
BT Group (LSE:BT.A)jumped 6.71% after reports on Virgin Media O2 fibre access talks and solid quarterly earnings.
-
Seplat Energy (LSE:SEPL)gained 4.84% following stronger third quarter results and a higher price target from Citi.
-
Diageo (LSE:DGE)rose 3.26% alongside broad FTSE 100 strength and fresh product launches across its premium spirits portfolio.
Top Losers
-
IQE (AIM:IQE)fell 11.67%.
-
Ecora Royalties (LSE:ECOR)declined 9.91%.
-
NatWest Group (LSE:NWG)dropped 8.75% after Q3 results and commentary raised concerns about future net interest income pressure.
On The Radar
UK investors face a packed few days where the Bank of England, key domestic earnings and US jobs data all feed directly into rate expectations, sterling and sector moves in London.
-
BoE Interest Rate Decision, Thu 5 Nov. The market is set for Bank Rate at 4% versus 3.75% previously, so a move away from that consensus would quickly reset borrowing costs, UK bank stocks and the pound.
-
BoE Monetary Policy Report and MPC Votes, Thu 5 Nov. The balance between hike, cut and hold votes, plus the updated projections, will shape how long UK rates are expected to stay restrictive and how UK domestically focused shares are priced.
-
Marks and Spencer Group, Wed 4 Nov. First half 2027 results put the spotlight on like for like store revenue and online profitability, which together provide a read on UK discretionary spending through the high street and clothing lines.
-
BT Group (BT.A), Thu 5 Nov. Q2 2027 numbers keep the focus on guidance and cash flow from its fibre rollout and mobile operations, because these influence how much room BT has for network investment versus balance sheet discipline.
-
US Non Farm Payrolls, Fri 6 Nov. The consensus sits at 65K versus 29K previously and any big miss or beat would shift US rate expectations, which often moves GBP/USD and feeds into FTSE 100 multinational valuations.
Sector & Industry Watch
Financials: Rate decision keeps lenders on edge
Financials have slipped over the past week, with the sector down a little over 3% while investors wait for the Bank of England call on Thursday. Banks have had an even rougher patch, which has fed into wider worries about loan demand and deposit costs.
If you hold UK funds heavy in Financials, the clearest swing factor is the BoE interest rate decision and vote split on 5 November, because that shapes expectations for future borrowing costs and bank profitability.
Energy: Oil strength feeds cash flow story
Energy is roughly flat over the last seven days after a strong run over the past year, helped by Oil and Gas moving in step. Elevated crude prices linked to Middle East supply risk keep attention on how much free cash UK listed producers can generate.
If you own Energy stocks, the next clean driver to watch is this week's US crude and gasoline inventory data, since any sharp move in oil prices quickly filters through to company earnings and dividends.
Metals and Mining: Resource squeeze meets softer prices
Metals and Mining have eased over the past week and month even though the 12 month return remains positive. Reports highlighting supply strain in copper and gold, including commentary around Anglo American and Chilean output, point to a tight raw materials backdrop while investor appetite has cooled recently.
If mining shares feature in your portfolio, focus on Thursday's euro area inflation flash reading, because any shift in price pressure can move expectations for European growth and metals demand that matter for UK listed miners.
Real Estate: Property rebound tests rate reality
Real Estate has pushed higher over the last week and month and now shows a gain of about 1.5% over seven days. Lower recent sector returns over 12 months mean this bounce now bumps into the question of whether higher debt costs will cap further progress.
If you own UK property companies or REITs, the pairing to watch is Thursday's UK Construction PMI and the BoE decision, since building activity and the cost of borrowing together influence values for offices, warehouses and housing related assets.
Healthcare: Pharma pipeline keeps sector in focus
Healthcare has risen over the past week, with Pharmaceuticals & Biotech advancing faster as AstraZeneca's lung cancer filing news supports sentiment. The sector also carries a solid one year gain while trading on P/E multiples that are slightly below its recent three year average.
If healthcare holdings sit in your ISA or pension, the key thing to track is company pipeline news such as AstraZeneca's regulatory progress, because successful trial results and approvals often affect share prices more than broad macro data.
Don't Wait For The Winners, Find Them
With the Bank of England decision set to keep rate risk front and centre, income focused investors can stress test their holdings against this list of 226 dividend fortresses .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
